These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 33145317)

  • 1. Management of hyponatremia associated with acute porphyria-proposal for the use of tolvaptan.
    Solares I; Tejedor M; Jericó D; Morales-Conejo M; Enríquez de Salamanca R; Fontanellas A; Tejedor-Jorge A
    Ann Transl Med; 2020 Sep; 8(17):1098. PubMed ID: 33145317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapidity of Correction of Hyponatremia Due to Syndrome of Inappropriate Secretion of Antidiuretic Hormone Following Tolvaptan.
    Morris JH; Bohm NM; Nemecek BD; Crawford R; Kelley D; Bhasin B; Nietert PJ; Velez JCQ
    Am J Kidney Dis; 2018 Jun; 71(6):772-782. PubMed ID: 29478867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SIADH-related hyponatremia in hospital day care units: clinical experience and management with tolvaptan.
    De Las Peñas R; Ponce S; Henao F; Camps Herrero C; Carcereny E; Escobar Álvarez Y; Rodríguez CA; Virizuela JA; López López R
    Support Care Cancer; 2016 Jan; 24(1):499-507. PubMed ID: 26431960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The treament of hyponatremia secundary to the syndrome of inappropriate antidiuretic hormone secretion].
    Runkle I; Villabona C; Navarro A; Pose A; Formiga F; Tejedor A; Poch E;
    Med Clin (Barc); 2013 Dec; 141(11):507.e1-507.e10. PubMed ID: 24169317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosing and Treating the Syndrome of Inappropriate Antidiuretic Hormone Secretion.
    Verbalis JG; Greenberg A; Burst V; Haymann JP; Johannsson G; Peri A; Poch E; Chiodo JA; Dave J
    Am J Med; 2016 May; 129(5):537.e9-537.e23. PubMed ID: 26584969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolvaptan Use to Treat SIADH in a Child.
    Koksoy AY; Kurtul M; Ozsahin AK; Cayci FS; Tayfun M; Bayrakci US
    J Pediatr Pharmacol Ther; 2018; 23(6):494-498. PubMed ID: 30697137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute Porphyrias.
    Besur S; Schmeltzer P; Bonkovsky HL
    J Emerg Med; 2015 Sep; 49(3):305-12. PubMed ID: 26159905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 'Dos and don'ts' in the management of hyponatremia.
    Aylwin S; Burst V; Peri A; Runkle I; Thatcher N
    Curr Med Res Opin; 2015; 31(9):1755-61. PubMed ID: 26173050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyponatremia in acute intermittent porphyria probably resulting from inappropriate secretion of antidiuretic hormone.
    LUDWIG GD; GOLDBERG M
    Ann N Y Acad Sci; 1963 Mar; 104():710-34. PubMed ID: 13931518
    [No Abstract]   [Full Text] [Related]  

  • 10. [Acute intermittent porphyria: a diagnostic dilemma].
    Gázquez Sisteré I; Luján Mavila K; Chordá Ribelles J; Touzón López C
    Gastroenterol Hepatol; 2010; 33(6):436-9. PubMed ID: 20435380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bortezomib-induced hyponatremia: tolvaptan therapy permits continuation of lenalidomide, bortezomib and dexamethasone therapy in relapsed myeloma.
    O'Connor-Byrne N; Glavey S; Tudor R; Murphy P; Thompson CJ; Quinn J
    Exp Hematol Oncol; 2019; 8():4. PubMed ID: 30733892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolvaptan Treatment in Children with Chronic Hyponatremia due to Inappropriate Antidiuretic Hormone Secretion: A Report of Three Cases.
    Tuli G; Tessaris D; Einaudi S; De Sanctis L; Matarazzo P
    J Clin Res Pediatr Endocrinol; 2017 Sep; 9(3):288-292. PubMed ID: 28515029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Edematous Hyponatremia Treated with Tolvaptan in a Patient with Amyotrophic Lateral Sclerosis.
    Kim GH
    Electrolyte Blood Press; 2017 Dec; 15(2):37-41. PubMed ID: 29399022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience with Tolvaptan for Euvolemic and Hypervolemic Hyponatremia in the Acute Care Setting.
    Olin JL; Mitchell G; Cremisi H
    Hosp Pharm; 2015 May; 50(5):380-5. PubMed ID: 26405324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An economic analysis of tolvaptan compared with fluid restriction among hospitalized patients with hyponatremia.
    Ramamohan V; Mladsi D; Ronquest N; Kamat S; Boklage S
    Hosp Pract (1995); 2017 Aug; 45(3):111-117. PubMed ID: 28449624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. THINK PORPHYRIA: CASE REPORT AND REVIEW OF LITERATURE.
    Straume Z; Skuja V; Proskurina A; Māliņa J; Hasnere S; Krupnova I; Lejnieks A; Derovs A
    Eksp Klin Gastroenterol; 2015; (7):69-77. PubMed ID: 26817125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, double blinded, placebo-controlled trial to evaluate the efficacy and safety of tolvaptan in Chinese patients with hyponatremia caused by SIADH.
    Chen S; Zhao JJ; Tong NW; Guo XH; Qiu MC; Yang GY; Liu ZM; Ma JH; Zhang ZW; Gu F
    J Clin Pharmacol; 2014 Dec; 54(12):1362-7. PubMed ID: 24906029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolvaptan corrects hyponatremia and relieves the burden of fluid/dietary restriction and hospitalization in hyponatremic patients with terminal lung cancer: a report of two cases.
    Kai K; Tominaga N; Koitabashi K; Ichikawa D; Shibagaki Y
    CEN Case Rep; 2019 May; 8(2):112-118. PubMed ID: 30637666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe symptomatic acute hyponatremia in traumatic brain injury responded very rapidly to a single 15 mg dose of oral tolvaptan; a Mayo Clinic Health System hospital experience - need for caution with tolvaptan in younger patients with preserved renal function.
    Onuigbo MAC; Agbasi N
    J Renal Inj Prev; 2017; 6(1):26-29. PubMed ID: 28487868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of hyponatremia induced by the syndrome of Inappropriate antidiuretic hormone secretion: a multidisciplinary spanish algorithm.
    Runkle I; Villabona C; Navarro A; Pose A; Formiga F; Tejedor A; Poch E
    Nefrologia; 2014; 34(4):439-50. PubMed ID: 25036057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.